氧化和相关的心律失常的风险
Hadi Farhat1, Celine J Kassab2, Yehya Tlaiss1
1Internal Medicine, University of Balamand, Beirut, Lebanon.
Global cardiology science & practice
|May 15, 2024
概括
氧化 (HCQ) 是一种安全有效的治疗类风湿性疾病的方法. 然而,长期使用可能会导致QT间隔延长和心律失常,特别是与其他药物结合使用时.
科学领域:
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
背景情况:
- 氧化 (HCQ) 是一种广泛使用的抗疟疾药物,由于其安全性,有效性和成本效益,现在用于类风湿性自身免疫性疾病.
- 它被认为是系统性红斑狼,Sjögren综合征和类风湿性关节炎等疾病的第一线治疗.
- 尽管它具有治疗效益,但长期使用HCQ与潜在的并发症有关,特别是心脏问题.
研究的目的:
- 审查氧化 (HCQ) 对风湿病患者的QT间隔的影响.
- 检查与HCQ相关的心律失常风险增加,特别是与其他药物联合使用时.
- 调查HCQ在孕妇中使用的安全性.
主要方法:
- 这项研究是叙事文献综述.
- 它专注于分析有关HCQ对QT间隔影响的现有研究.
- 该审查特别涉及药物相互作用和怀孕期间的安全性.
主要成果:
- 氧化 (HCQ) 可以延长QT间隔,增加心律失常的风险.
- 同时使用HCQ和某些药物,如阿齐思罗米,可能会进一步提高这种风险.
- 怀孕期间HCQ的安全性需要仔细考虑.
结论:
- 虽然HCQ是一种有价值的类风湿性疾病的治疗方法,但临床医生必须监测QT间隔延长和心律失常风险.
- 对潜在的药物相互作用的认识对于安全的HCQ处方至关重要.
- 可能需要进一步的研究,以充分阐明HCQ在特定人群中的安全性,包括孕妇.
更多相关视频
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.8K
相关概念视频
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
978
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
978
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
740
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
740
01:28Mechanism of Cardiac Arrhythmias
917
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
917
01:28Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
830
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
830